Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

54.35 +5.81 (+11.97%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stay informed with the top movers within the S&P500 index on Tuesday. ↗
Via Chartmill
News headline image
The mRNA Pivot: Moderna Navigates Regulatory Headwinds and Tariff Turmoil in a Volatile 2026 Biotech Landscape
As the 44th Annual J.P. Morgan Healthcare Conference concludes in early January 2026, Moderna, Inc. (NASDAQ: MRNA) finds itself at a critical crossroads. Once the darling of the pandemic era, the... 
Via MarketMinute
Topics Economy Intellectual Property World Trade
Top S&P500 movers in Monday's session ↗
Via Chartmill
Gapping S&P500 stocks in Monday's session ↗
Via Chartmill
What's going on in today's session: S&P500 movers ↗
Via Chartmill
These S&P500 stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
Moderna Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference
Via ACCESS Newswire
News headline image
BioNTech Finalizes CureVac Acquisition: A Strategic Consolidation Met with Market Skepticism
In a move that signals the end of an era for independent mRNA pioneers, BioNTech SE (Nasdaq: BNTX) has officially completed its acquisition of longtime rival CureVac N.V. (Nasdaq: CVAC). The... 
Via MarketMinute
Topics Intellectual Property
News headline image
Moderna’s Second Act: A 2026 Deep Dive into the Future of mRNA Therapeutics
Today’s Date: January 9, 2026 Introduction As we enter the first weeks of 2026, Moderna, Inc. (NASDAQ: MRNA) finds itself at a defining crossroads. Once the poster child for the biotech boom of the... 
Via PredictStreet
Topics Initial Public Offering Intellectual Property
News headline image
3 Unprofitable Stocks We Keep Off Our Radar
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth. 
Via StockStory
News headline image
Dow Jones Erases Record Highs in 200-Point Reversal as Economic Data Shifts
The Dow Jones Industrial Average (DJIA) experienced a jarring reversal on Wednesday, January 7, 2026, tumbling more than 200 points after hitting a fresh all-time high earlier in the session. The... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Wall Street Shatters Records: S&P 500 and Dow Hit Historic Intraday Highs Amid AI Surge and Geopolitical Shifts
The U.S. stock market entered uncharted territory on Wednesday, January 7, 2026, as the S&P 500 and the Dow Jones Industrial Average both climbed to fresh all-time intraday highs. Driven by a potent... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
Moderna’s Second Act: Analyzing the 2026 Pipeline Pivot and Recent Stock Surge
Date: January 7, 2026 Introduction Moderna, Inc. (NASDAQ: MRNA), once the definitive poster child of the COVID-19 pandemic response, is currently undergoing one of the most significant pivots in the... 
Via PredictStreet
Topics Economy Initial Public Offering Intellectual Property
News headline image
My Top 5 Stocks to Buy in Early 2026 ↗
These companies are leaders in their fields. 
Via The Motley Fool
Topics Artificial Intelligence
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
These S&P500 stocks are moving in today's session ↗
Via Chartmill
News headline image
Moderna Announces Global Regulatory Submissions for Its Investigational Seasonal Influenza Vaccine
Via ACCESS Newswire
News headline image
Pfizer’s Dividend Trap or Deep Value? Analyzing the Pharma Giant as Shares Languish Below $30
As the calendar turns to January 1, 2026, Pfizer Inc. (NYSE: PFE) finds itself in a position that would have been unthinkable during the height of the pandemic. Once the darling of the pharmaceutical... 
Via MarketMinute
Topics Intellectual Property
Stay informed with the top movers within the S&P500 index on Wednesday. ↗
Via Chartmill
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
News headline image
Discover which S&P500 stocks are making waves on Tuesday. ↗
Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
News headline image
1 Mooning Stock to Own for Decades and 2 We Find Risky
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or... 
Via StockStory
News headline image
S&P 500 Tests Critical Support: Can the Bull Market Survive the Year-End Pullback?
As the sun sets on a historic 2025, the S&P 500 (NYSE:SPY) is facing a moment of technical reckoning. After reaching a breathtaking all-time high of 6,932.05 on Christmas Eve, the index has entered a... 
Via MarketMinute
Topics Artificial Intelligence Bonds Earnings
News headline image
Market Breather: Benchmarks Pause Record-Breaking Year as Volatility Signals Year-End Reset
As the final trading days of 2025 approach, the relentless momentum that propelled major U.S. indices to historic heights has entered a period of measured consolidation. After a year defined by the... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Forget Moderna Stock, This is a Much Better Buy ↗
This stock is a great choice for cautious and aggressive investors. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Discover which S&P500 stocks are making waves on Friday. ↗
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Friday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
News headline image
Uncover the latest developments among S&P500 stocks in today's session. ↗
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday. 
Via Chartmill
News headline image
These S&P500 stocks are gapping in today's session ↗
Looking for the S&P500 stocks that are experiencing notable gaps on Friday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session. 
Via Chartmill
News headline image
S&P 500 Scales New Heights: Record-Breaking 2025 Sets the Stage for a High-Stakes 2026
The S&P 500 index has concluded 2025 on a historic high, defying early-year skepticism and navigating significant geopolitical shifts to reach unprecedented levels. As of the final full week of trading... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Pfizer’s 2026 Outlook Misses the Mark as Post-Pandemic Hangover and Patent Cliff Loom
NEW YORK — On December 16, 2025, Pfizer (NYSE:PFE) issued a conservative financial outlook for the 2026 fiscal year, falling short of Wall Street’s expectations and signaling a prolonged period of... 
Via MarketMinute
Topics Economy Intellectual Property
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.